Substance / Medication

Dolasetron mesylate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

97 trials linked to this intervention

97
Total Trials
10
Recruiting
18
With Results

Research Evidence

Published studies and systematic reviews

Sort:
The Impact of Acupuncture on Pain Intensity, Nausea, and Vomiting for Laparoscopic Cholecystectomy: A Meta-analysis Study.
Tang Xi, Qu Shijie · Surg Laparosc Endosc Percutan Tech · 2025
PMID: 39618188Meta-Analysis
Penehyclidine Hydrochloride: A Promising Antimuscarinic Agent for PONV Prophylaxis in Diverse Surgical Procedures.
Abo Zeid Mohamed, El-Nablaway Mohammad, Elrosasy Amr et al. · J Perianesth Nurs · 2025
PMID: 39818664Meta-Analysis
CYP2D6 genotype and associated 5-HTreceptor antagonist outcomes: A systematic review and meta-analysis.
Moore Claire, Williams Elizabeth, Dyas Roxanne et al. · Clin Transl Sci · 2025
PMID: 39899439Meta-AnalysisFull text (PMC)
CdS nanocrystals as fluorescent probe for detection of dolasetron mesylate in aqueous solution: Application to biomedical analysis.
Pawar Samadhan P, Walekar Laxman S, Kondekar Uttam R et al. · J Pharm Anal · 2016
PMID: 29404011OtherFull text (PMC)
Stability and sterility of dolasetron mesylate in syringes stored at room temperature.
Steiner MaryAnn E, Lensmeyer Gary, Vermeulen Lee C · Am J Health Syst Pharm · 2005
PMID: 15851493Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dolasetron mesilate (substance)
SNOMED CT
108422002
UMLS CUI
C0065818

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
97
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.